Pulse Biosciences, Inc. (PLSE) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 1.19M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $1.19M | (m) | (m) |
| 2026-03-31 | (m) | $751.00K | (m) | (m) |
| 2025-12-31 | (m) | $350.00K | (m) | (m) |
| 2025-09-30 | (m) | $86.00K | (m) | (m) |
| 2025-06-30 | (m) | $0.00 | (m) | (m) |
| 2025-03-31 | (m) | $0.00 | (m) | (m) |
| 2024-12-31 | (m) | $0.00 | (m) | (m) |
| 2024-09-30 | (m) | $0.00 | (m) | (m) |
| 2024-06-30 | (m) | $0.00 | (m) | (m) |
| 2024-03-31 | (m) | $0.00 | (m) | (m) |
| 2023-12-31 | (m) | $0.00 | (m) | (m) |
| 2023-09-30 | (m) | $-9.00K | (m) | (m) |
| 2023-06-30 | (m) | $-9.00K | (m) | (m) |
| 2023-03-31 | (m) | $256.00K | (m) | (m) |
| 2022-12-31 | (m) | $700.00K | (m) | (m) |
| 2022-09-30 | (m) | $1.55M | (m) | (m) |
| 2022-06-30 | (m) | $2.13M | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.42M | $600.00K | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $0.00 | $500.00K | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |